Articles with public access mandates - Sebastien BonnetLearn more
Not available anywhere: 11
FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension
A Bourgeois, C Lambert, K Habbout, B Ranchoux, S Paquet-Marceau, ...
Journal of Molecular Medicine 96, 223-235, 2018
Mandates: Heart and Stroke Foundation of Canada
Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic review
G Rival, Y Lacasse, S Martin, S Bonnet, S Provencher
Chest 146 (3), 686-708, 2014
Mandates: Fonds de recherche du Québec - Santé
Pulmonary arterial hypertension: New pathophysiological insights and emerging therapeutic targets
A Bourgeois, J Omura, K Habbout, S Bonnet, O Boucherat
The international journal of biochemistry & cell biology 104, 9-13, 2018
Mandates: Heart and Stroke Foundation of Canada
MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
A Courboulin, B Ranchoux, S Cohen-Kaminsky, F Perros, S Bonnet
Current opinion in oncology 28 (1), 72-82, 2016
Mandates: Canadian Institutes of Health Research, National Institute of Health and …
miRNAs in PAH: biomarker, therapeutic target or both?
J Meloche, A Pflieger, M Vaillancourt, C Graydon, S Provencher, S Bonnet
Drug discovery today 19 (8), 1264-1269, 2014
Mandates: Canadian Institutes of Health Research
Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension
ED de la Roque, JP Savineau, S Bonnet
Pharmacology & therapeutics 126 (2), 186-199, 2010
Mandates: Canadian Institutes of Health Research
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension
O Boucherat, T Yokokawa, V Krishna, S Kalyana-Sundaram, S Martineau, ...
Nature cardiovascular research 1 (8), 748-760, 2022
Mandates: Fonds de recherche du Québec - Santé
Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension
P Chelladurai, C Kuenne, A Bourgeois, S Günther, C Valasarajan, ...
Science Translational Medicine 14 (648), eabe5407, 2022
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Trial duration and risk reduction in combination therapy trials for pulmonary arterial hypertension: a systematic review
AC Lajoie, CA Guay, JC Lega, G Lauzière, S Simard, C Lambert, ...
Chest 153 (5), 1142-1152, 2018
Mandates: Fonds de recherche du Québec - Santé
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent Models
M Bisserier, O Boucherat, S Bonnet, L Hadri
Cardiac Gene Therapy: Methods and Protocols, 263-278, 2022
Mandates: US National Institutes of Health, American Heart Association
Hypusine signaling promotes pulmonary vascular remodeling in pulmonary arterial hypertension
SE Lemay, Y Grobs, C Romanet, S Martineau, M Salem, T Shimauchi, ...
American Journal of Respiratory and Critical Care Medicine, 2024
Mandates: Fonds de recherche du Québec - Santé
Available somewhere: 96
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ...
Circulation 141 (9), e139-e596, 2020
Mandates: US National Institutes of Health
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
M Humbert, C Guignabert, S Bonnet, P Dorfmüller, JR Klinger, MR Nicolls, ...
European Respiratory Journal 53 (1), 2019
Mandates: US National Institutes of Health
Role for miR-204 in human pulmonary arterial hypertension
A Courboulin, R Paulin, NJ Giguère, N Saksouk, T Perreault, J Meloche, ...
Journal of Experimental Medicine 208 (3), 535-548, 2011
Mandates: Canadian Institutes of Health Research
Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats
T van Haaften, R Byrne, S Bonnet, GY Rochefort, J Akabutu, ...
American journal of respiratory and critical care medicine 180 (11), 1131-1142, 2009
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Fatty acid oxidation and malonyl-CoA decarboxylase in the vascular remodeling of pulmonary hypertension
G Sutendra, S Bonnet, G Rochefort, A Haromy, KD Folmes, ...
Science translational medicine 2 (44), 44ra58-44ra58, 2010
Mandates: Canadian Institutes of Health Research
Role for DNA damage signaling in pulmonary arterial hypertension
J Meloche, A Pflieger, M Vaillancourt, R Paulin, F Potus, S Zervopoulos, ...
Circulation 129 (7), 786-797, 2014
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
The role of Nogo and the mitochondria–endoplasmic reticulum unit in pulmonary hypertension
G Sutendra, P Dromparis, P Wright, S Bonnet, A Haromy, Z Hao, ...
Science translational medicine 3 (88), 88ra55-88ra55, 2011
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Sirtuin 3 Deficiency Is Associated with Inhibited Mitochondrial Function and Pulmonary Arterial Hypertension in Rodents and Humans
R Paulin, P Dromparis, G Sutendra, V Gurtu, S Zervopoulos, L Bowers, ...
cell metabolism, 2014
Mandates: Canadian Institutes of Health Research
Downregulation of microRNA-126 contributes to the failing right ventricle in pulmonary arterial hypertension
F Potus, G Ruffenach, A Dahou, C Thebault, S Breuils-Bonnet, ...
Circulation 132 (10), 932-943, 2015
Mandates: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada
Publication and funding information is determined automatically by a computer program